Ficus Capital

Morpheus Labs is a blockchain platform and service provider that enables developers to rapidly build, deploy, and scale applications. The platform offers a low-code workflow automation tool that bridges Web2 and Web3, enabling data exchange and interoperability across networks while maintaining secure and reliable workflow operations. It supports end-to-end Web3 transformation through an integrated system that combines multi-chain and off-chain automation powered by AI, and offers templates and a proprietary technology stack to accelerate solution delivery. By simplifying blockchain adoption and offering a unified platform, Morpheus Labs helps organizations implement Web3 applications with reduced time and cost.

Simplify, one of the World’s 50 Most Innovative Companies, creates a marketplace for users to buy and sell excess Internet bandwidth from their monthly home broadband and mobile plans. The company extends sharing economy to the broadband space, enabling everyone to be a little Internet Service Provider. The service dynamically creates an encrypted hotspot password so that any buyers can seamlessly piggyback on another person's internet access on the fly. Headquartered in Malaysia, Simplify idea was validated and refined at Massachusetts Institute of Technology (MIT). The technology that powered Simplify has since granted a US Patent.

Assemblr is an augmented reality platform that facilitates the creation, discovery, and sharing of AR experiences. It allows users to visualize information through interactive 3D content, making it accessible to a wide audience. The platform includes both mobile and desktop applications, enabling users to create AR projects or upload custom 3D models from existing software. Users can seamlessly access and share augmented reality content anytime and anywhere. In the near future, Assemblr plans to introduce a monetization feature, allowing users to join the Assemblr Certified Creator program to develop AR projects for others or sell 3D assets in the Assemblr Marketplace for use in AR applications.

Eolo Pharma is a pharmaceutical company dedicated to researching and developing molecular drugs aimed at treating chronic inflammation and its related diseases. Its primary focus lies in creating targeted small-molecule therapies, including thermogenic compounds like MVD1, to manage obesity, type 2 diabetes, and neurodegenerative disorders more effectively.